Toxicology studies in mice and dogs administered MTX-531
Ended Awarded Last action
- Contract number
- 75N91024F00002
- Awardee
-
IIT Research Institute UEI DGBUFQYMKWB5 Part of Illinois Institute Of Technology
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,790,042
Award facts
- Contract value 100% obligated
- $1,790,042.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Chicago, IL 60616, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $0 | |
| Change Order | $451,034 | |
| Original award | $1,339,008 |
About this award
This is a $1,790,042.00 Delivery Order Contract awarded by the National Cancer Institute (NCI) to the IIT Research Institute (IITRI), a non-profit subsidiary of the Illinois Institute of Technology (IIT). The contract is for toxicology studies in mice and dogs administered MTX-531, which does not have a set-aside designation. IITRI is a leading preclinical contract research organization that specializes in providing drug development services to federal agencies like the NCI, NIAID, NINDS, and NCATS. The contract is part of IITRI's extensive portfolio of federal Indefinite Delivery/Indefinite Quantity (IDIQ) vehicles, including a $149.995 million PREVENT Cancer Preclinical Drug Development Program with NCI and a $48.6 million safety evaluation and toxicology contract with NCATS. IITRI's expertise in non-GLP and GLP studies, analytical assay development, and process validation supports the advancement of promising therapies from discovery through clinical trials.
Quick answers
Who was awarded contract 75N91024F00002?
75N91024F00002 was awarded to IIT Research Institute by National Cancer Institute (National Institutes of Health) on June 12, 2024.
How much is contract 75N91024F00002 worth?
The government has obligated $1,790,042 on 75N91024F00002.
Is contract 75N91024F00002 an order under another contract?
Yes. 75N91024F00002 is a delivery order under 75N91022D00016, an indefinite delivery contract.
Was contract 75N91024F00002 competed?
The extent of competition for 75N91024F00002 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award